510(k) K251604
K251604 is an FDA 510(k) premarket notification submitted by Access Bio, Inc. for the device "CareSuperb COVID-19/Flu A&B Antigen Combo Home Test". The FDA issued a decision of Substantially Equivalent on Aug 22, 2025. The device falls under product code SCA (Multi-Analyte Respiratory Virus Antigen Detection Test), a Class II device regulated under 21 CFR 866.3987. Access Bio, Inc. has 2 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Aug 22, 2025
- Date Received
- May 27, 2025
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Multi-Analyte Respiratory Virus Antigen Detection Test
- Device Class
- Class II
- Regulation Number
- 866.3987
- Review Panel
- MI
- Submission Type
- 510(k)
A multi-analyte respiratory virus antigen detection test is an in vitro diagnostic device intended for the detection and/or differentiation of respiratory viruses directly from respiratory clinical specimens. The device is intended to be performed at the site of sample collection, does not involve sample storage and/or transport.
Need the full FDA record for Access Bio, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.